These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26885720)

  • 1. Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up.
    Alibaz-Oner F; Aksu K; Yentur SP; Keser G; Saruhan-Direskeneli G; Direskeneli H
    Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S73-6. PubMed ID: 26885720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokine profiles in Takayasu's arteritis: search for biomarkers.
    Alibaz-Oner F; Yentür SP; Saruhan-Direskeneli G; Direskeneli H
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-32-5. PubMed ID: 25436391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study on the association of serum pentraxin-3 and lysosomal-associated membrane protein-2 levels with disease activity in Chinese Takayasu's arteritis patients.
    Chen Z; Hu C; Sun F; Li J; Yang Y; Tian X; Zeng X
    Clin Exp Rheumatol; 2019; 37 Suppl 117(2):109-115. PubMed ID: 30943132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3 is more accurate than C-reactive protein for Takayasu arteritis activity assessment: A systematic review and meta-analysis.
    Wen X; Hou R; Xu K; Han Y; Hu J; Zhang Y; Su Y; Gao J; Zhang G; Zhang L
    PLoS One; 2021; 16(2):e0245612. PubMed ID: 33529185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study.
    Pulsatelli L; Boiardi L; Assirelli E; Pazzola G; Muratore F; Addimanda O; Dolzani P; Versari A; Casali M; Magnani L; Pignotti E; Pipitone N; Croci S; Meliconi R; Salvarani C
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):102-110. PubMed ID: 28466804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The establishment and validation of reference intervals for plasma Pentraxin-3 in healthy volunteers and patients with Takayasu's arteritis.
    Zhou X; Han Q; Wang X; Zhang M; Li X; Ma W; Wang X; Yang W; Zhu P; Wang J; Kang F
    Clin Chim Acta; 2022 Dec; 537():146-153. PubMed ID: 36279941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients.
    Kang F; Han Q; Zhou X; Zheng Z; Wang S; Ma W; Zhang K; Quan Z; Yang W; Wang J; Zhu P
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3107-3117. PubMed ID: 32567005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu.
    Aydin SZ; Yilmaz N; Akar S; Aksu K; Kamali S; Yucel E; Karadag O; Bicakcigil M; Ozer H; Kiraz S; Onen F; Inanc M; Keser G; Akkoc N; Direskeneli H
    Rheumatology (Oxford); 2010 Oct; 49(10):1889-93. PubMed ID: 20542893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
    Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
    Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of endothelial damage and repair in Takayasu arteritis: are they associated with disease activity?
    Dogan S; Piskin O; Solmaz D; Akar S; Gulcu A; Yuksel F; Cakır V; Sari I; Akkoc N; Onen F
    Rheumatol Int; 2014 Aug; 34(8):1129-38. PubMed ID: 24413630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Patients with Takayasu Arteritis in Routine Practice with Indian Takayasu Clinical Activity Score.
    Alibaz-Oner F; Aydin SZ; Akar S; Aksu K; Kamali S; Yucel E; Karadag O; Ozer H; Kiraz S; Onen F; Inanc M; Keser G; Akkoc N; Direskeneli H
    J Rheumatol; 2015 Aug; 42(8):1443-7. PubMed ID: 26136490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).
    Misra R; Danda D; Rajappa SM; Ghosh A; Gupta R; Mahendranath KM; Jeyaseelan L; Lawrence A; Bacon PA;
    Rheumatology (Oxford); 2013 Oct; 52(10):1795-801. PubMed ID: 23594468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu's arteritis.
    Erdal S; Nalbantoğlu B; Gür MB; Yıldırım M; Kılıçarslan A; Kaymaz-Tahra S; Alibaz-Öner F; Yay M; Mumcu G; Direskeneli H
    Clin Rheumatol; 2021 Oct; 40(10):4109-4116. PubMed ID: 33839991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YKL-40 as a new biomarker of disease activity in Takayasu arteritis.
    Sun Y; Kong X; Wu S; Ma L; Yan Y; Lv P; Jiang L
    Int J Cardiol; 2019 Oct; 293():231-237. PubMed ID: 31303395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscopic colitis in patients with Takayasu's arteritis: a potential association between the two disease entities.
    Kanıtez NA; Toz B; Güllüoğlu M; Erer B; Esen BA; Omma A; Şahinkaya Y; İliaz R; Çavuş B; Gül A; İnanç M; Karaca Ç; Kamalı S
    Clin Rheumatol; 2016 Oct; 35(10):2495-9. PubMed ID: 26742755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al.
    De Luca G; Cavalli G; Baldissera E; Dagna L
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):221. PubMed ID: 28375830
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitamin D Levels in Takayasu's Arteritis and a Review of the Literature on Vasculitides.
    Alibaz-Oner F; Asmaz-Haliloglu Ö; Gogas-Yavuz D; Can M; Haklar G; Direskeneli H
    J Clin Lab Anal; 2016 Sep; 30(5):529-33. PubMed ID: 26661754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis.
    Pan LL; Du J; Gao N; Liao H; Wan J; Ci WP; Yang C; Wang T
    Clin Rheumatol; 2016 Dec; 35(12):3031-3036. PubMed ID: 27629397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
    Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
    Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
    Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
    Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.